1. Wormser Gary, P., Dattwyler Raymond, J., Shapiro Eugene, D., Halperin John, J., Steere, A.: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic Anaplasmosisa and Babesiosis: clinical practice guidelines by the infection diseases society of America. Clin. Infect. Dis. 43, 1089–1134 (2006)
2. Asch, E.S., Bujak, D.I., Weiss, M., Peterson, M.G., Weinstein, A.: Lyme disease: an infectious and post infectious syndrome. J. Rheumatol. 21, 454–461 (1994)
3. Shadick, N.A., Phillips, C.B., Logigian, E.L., Steera, A.C., Kaplan, R.F.: The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Annals Internal Med. 121, 560–567 (1994)
4. Klempner, M.S., Hu, L.T., Evans, J., Schmid, C.H., Johnson, G.M.: Two controlled trials of antibiotic treatment in patients symptoms and a history of Lyme disease. N. Engl. J. Med. 345, 85–92 (2001)
5. Wormser, G.P., Philipp, M.T., Marques, A.R., Bittkers Marlin, D.S.: A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Cin. Diagn. Lab. Immunol. 12, 1069–1074 (2005)